✦ LIBER ✦

Paraphilia and other disturbed behavior associated with dopamimetic treatment for Parkinson's disease

✍ Scribed by Olav B. Nielssen; Raymond J. Cook; Ron Joffe; Linton J. Meagher; Paul Silberstein

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 217 KB
Volume: 24
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.22388

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current treatment of dementia with Lewy

Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease

✍ David J. Burn; Ian G. McKeith 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Dementia in Parkinson's disease (PDD) is a frequent and distressing complication with major consequences. Clinical and pathological features closely link PDD and dementia with Lewy bodies (DLB), suggesting they represent part of the same disease spectrum. Although dopaminergic deficiency primarily d

Olanzapine versus placebo in the treatme

Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease

✍ Peter Paul De Deyn; Manuel Martín Carrasco; Walter Deberdt; Claude Jeandel; Dona 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

## Abstract ## Objectives Psychotic symptoms and behavioral disturbances are a concern in the care of elderly patients with Alzheimer's dementia (AD). This study was conducted to compare the efficacy of olanzapine versus placebo in patients with psychotic symptoms associated with AD in long‐term o

Gender, aggression and serotonergic func

Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease

✍ Krista L. Lanctôt; Nathan Herrmann; Robert van Reekum; Goran Eryavec; Claudio A. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

## Background: Indications for serotonergic medications in the treatment of behavioral disorders associated with alzheimer's disease (ad) remain to be established. ## Method: Sertraline (100 mg od) was evaluated in a double-blind, randomized, placebo-controlled cross-over study in 22 nondepressed

Beyond the iron mask: Towards better rec

Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease

✍ David J. Burn 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

This review examines the frequency of depression complicating Parkinson's disease (PD), its aetiology and clinical features, and also how it may be recognised and treated. Studies investigating the frequency of depression in PD have yielded figures ranging between 2.7% and 70%. Methodological differ

Association of DRD3 and GRIN2B with impu

Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease

✍ Jee-Young Lee; Eun Kyung Lee; Sung Sup Park; Ji-Yeon Lim; Hee Jin Kim; Ji Sun Ki 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract We aimed to assess whether allelic variants of dopamine receptor, glutamate receptor, and serotonin transporter genes are associated with the appearance of impulse control and related behaviors (ICRB) in Parkinson's disease (PD) with dopamine replacement therapy (DRT). We surveyed ICRB

APOLIPOPROTEIN E IS ASSOCIATED WITH ISLE

APOLIPOPROTEIN E IS ASSOCIATED WITH ISLET AMYLOID AND OTHER AMYLOIDOSES: IMPLICATIONS FOR ALZHEIMER'S DISEASE

✍ CHARGÉ, SOPHIE B. P.; ESIRI, MARGARET M.; BETHUNE, CLAIRE A.; HANSEN, BARBARA C. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 652 KB

Apolipoprotein E (ApoE) has recently been proposed as an aetiological factor of Alzheimer's disease (AD): ApoE is co-localized to amyloid plaques and neurofibrillary tangles in the brain and binds to AP-protein in vitvo. An association of ApoE e4 allele with the development of AD has been reported.